Although viral-vectored vaccines have been used primarily for the induction of high levels of CD8+ T cells against the liver-stage of malaria, heterologous prime-boost vaccination with ChAd63 followed by MVA also induces strong antibodies responses41. This evidence concerns the gene CD8A and malaria.